CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Stock Down 100.0%
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Articles
- Five stocks we like better than CardioGenics
- What is the FTSE 100 index?
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- What is a Low P/E Ratio and What Does it Tell Investors?
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
